Balchem Corporation (NASDAQ:BCPC) Just Reported Decreased Shorts

December 8, 2017 - By Peter Erickson

 Balchem Corporation (NASDAQ:BCPC) Just Reported Decreased Shorts

Investors sentiment decreased to 1.14 in 2017 Q2. Its down 0.02, from 1.16 in 2017Q1. It fall, as 20 investors sold Balchem Corporation shares while 56 reduced holdings. 24 funds opened positions while 63 raised stakes. 26.48 million shares or 2.22% less from 27.08 million shares in 2017Q1 were reported.
Assetmark accumulated 416 shares. State Board Of Administration Of Florida Retirement Sys invested in 0% or 20,878 shares. Teachers Retirement System Of The State Of Kentucky reported 0.01% in Balchem Corporation (NASDAQ:BCPC). Moreover, Sei has 0% invested in Balchem Corporation (NASDAQ:BCPC) for 2,465 shares. Cambridge Investment Research Advsrs stated it has 3,614 shares. Bath Savings Trust holds 1.32% or 61,450 shares. Susquehanna Llp invested 0% of its portfolio in Balchem Corporation (NASDAQ:BCPC). 1,364 are held by Riverhead Cap Mngmt Limited Liability Company. Morgan Stanley reported 32,389 shares. 23,266 are held by Texas Permanent School Fund. Conestoga Advsr Limited Liability Co invested in 358,044 shares or 1.45% of the stock. Ubs Asset Americas Inc has invested 0% in Balchem Corporation (NASDAQ:BCPC). 3,156 were accumulated by Shelton. Rocky Mountain Advisers Llc holds 0.01% or 20 shares in its portfolio. Gemmer Asset Ltd Liability, a California-based fund reported 163 shares.

Since June 15, 2017, it had 0 buys, and 1 sale for $207,334 activity.

The stock of Balchem Corporation (NASDAQ:BCPC) registered a decrease of 25.93% in short interest. BCPC’s total short interest was 871,600 shares in December as published by FINRA. Its down 25.93% from 1.18M shares, reported previously. With 62,700 shares average volume, it will take short sellers 14 days to cover their BCPC’s short positions. The short interest to Balchem Corporation’s float is 2.78%.

The stock decreased 0.24% or $0.2 during the last trading session, reaching $84.53. About 87,979 shares traded or 7.73% up from the average. Balchem Corporation (NASDAQ:BCPC) has risen 37.77% since December 8, 2016 and is uptrending. It has outperformed by 21.07% the S&P500.

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries in the United States and internationally. The company has market cap of $2.71 billion. The companyÂ’s Human Nutrition & Health segment offers creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, cereals, grain based snacks, and cereal based ingredients; microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. It has a 42.69 P/E ratio. The Company’s Animal Nutrition & Health segment provides microencapsulated products that enhance health and milk production in ruminant animals; chelation technology, which provides enhanced nutrient absorption for species; and choline chloride, an essential nutrient for monogastric animal health.

Balchem Corporation (NASDAQ:BCPC) Ratings Coverage

Among 2 analysts covering Balchem (NASDAQ:BCPC), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Balchem has $60 highest and $6000 lowest target. $60’s average target is -29.02% below currents $84.53 stock price. Balchem had 3 analyst reports since March 8, 2016 according to SRatingsIntel. On Tuesday, March 8 the stock rating was downgraded by Sidoti to “Neutral”. The firm has “Sell” rating given on Friday, August 4 by Pivotal Research. The firm has “Sell” rating by Pivotal Research given on Friday, November 4.

More important recent Balchem Corporation (NASDAQ:BCPC) news were published by: which released: “Balchem Corporation Announces Quarterly Conference Call for Second Quarter …” on July 25, 2017, also published article titled: “Balchem Corporation Reports Third Quarter Sales of $150.7 Million with Record …”, published: “Health Products Drive Balchem Corporation’s Growth” on March 01, 2017. More interesting news about Balchem Corporation (NASDAQ:BCPC) was released by: and their article: “Balchem Corporation Acquires Innovative Food Processors, Inc.” with publication date: June 02, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: